Immunotherapy is a preferred option for oral cancer patients during COVID-19 pandemic? Chu C, Sun Y, Pan Y. Oral Oncol 2020 Jun 15:104860. doi: 10.1016/j.oraloncology.2020.104860.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chu C, Sun Y, Pan Y. Immunotherapy is a preferred option for oral cancer patients during COVID-19 pandemic? Oral Oncol 2020 Jun 15:104860. doi: 10.1016/j.oraloncology.2020.104860.
PMID: 32571643